Added to YB: 2025-05-01
Pitch date: 2025-04-29
INMD [neutral]
InMode Ltd.
+1.97%
current return
Author Info
No bio for this author
Company Info
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Market Cap
$943.7M
Pitch Price
$14.23
Price Target
N/A
Dividend
N/A
EV/EBITDA
3.83
P/E
6.51
EV/Sales
1.11
Sector
Health Care Equipment and Supplies
Category
turnaround
InMode presents Q1 2025 results
INMD (earnings update): Q1 revenue $77.9M (-3% Y/Y), EPS $0.31 (-3% Y/Y). Declining sales, margins (79%, -100bps) despite exceeding revenue expectations. 27% share buyback helping EPS but program now paused. 2025 guidance cut again: rev $395-405M, EPS $1.64-1.68. US tariffs impacting margins 2-3%. New platforms (OptimasMAX, Ignite) launched; consumable usage -30% YoY.
Read full article (3 min)